NeuronBC MFT-900 Non-Destructive Container Closure Integrity Tester (CCIT) for Vials and Pre-Filled Syringes

Overview

The NeuronBC MFT-900 is a precision-engineered, non-destructive Container Closure Integrity Tester (CCIT) designed specifically for pharmaceutical primary packaging verification. It employs the vacuum decay method—also known as differential pressure decay testing—to quantitatively assess seal integrity of rigid and semi-rigid containers without compromising product sterility or stability. This principle relies on measuring minute pressure differentials across a sealed test chamber under controlled vacuum conditions; any deviation from expected decay kinetics indicates leakage, which the system then correlates to an equivalent defect size in micrometers (µm). The MFT-900 meets the scientific and regulatory expectations outlined in USP “Package Integrity Evaluation – Sterile Products”, ASTM F2338-22 “Standard Test Method for Nondestructive Detection of Leaks in Packages by Vacuum Decay Method”, and aligns with current FDA guidance for alternative CCIT methods in lieu of probabilistic microbial challenge tests.

Key Features

• Vacuum decay-based measurement with high-resolution differential pressure sensing (0.1 Pa resolution) and dual-range pressure control (–0.1 to 1.0 MPa)
• Automated conversion of measured leak rate to equivalent circular hole diameter (down to 2 µm), enabling direct correlation with microbial ingress risk thresholds
• Integrated NIST-traceable certified reference leak standards for routine performance qualification and periodic recalibration
• Four-tier user access control with password authentication, electronic signatures, and full compliance with FDA 21 CFR Part 11 requirements for electronic records and signatures
• Comprehensive audit trail logging—including operator actions, parameter changes, test results, and system events—with minimum 5-year retention and time-stamped searchable archives
• Modular, split-system architecture: upper test chamber is interchangeable to accommodate vials (including 2R–50R ampoules), pre-filled syringes (PFS), cartridges, West stoppers, BFS/FFS containers, and specialized aerosol actuator assemblies
• Intuitive 10-inch color touchscreen HMI with guided workflow navigation—operators initiate tests via preloaded SOPs, insert/remove samples manually, and receive real-time pass/fail feedback with numerical leak metrics

Sample Compatibility & Compliance

The MFT-900 supports a broad spectrum of pharmaceutical container formats requiring deterministic integrity assurance. Validated configurations include glass and polymer ampoules (1–20 mL), lyophilized vials (2R–50R), rubber-stoppered West-type vials, pre-filled syringes (1–5 mL), blow-fill-seal (BFS) unit-dose containers, form-fill-seal (FFS) pouches, and metered-dose inhaler (MDI) systems with piston, bag-on-valve, or elastomeric actuator designs. All test methods are developed per ICH Q5C and aligned with ISO 11607-1/-2 for packaging validation. System qualification follows IQ/OQ/PQ protocols compliant with EU Annex 15 and ASTM E2500-13. The instrument’s hardware and firmware architecture supports GMP-compliant operation in QC laboratories subject to FDA, EMA, PMDA, and NMPA inspections.

Software & Data Management

• Embedded Windows-based OS with dedicated CCIT software featuring method library management, multi-batch reporting, and statistical process control (SPC) charting
• Raw sensor data, pressure decay curves, pass/fail decisions, and operator metadata stored locally with optional network backup
• Data export via USB to CSV or PDF formats; compatible with LIMS integration through RS485 or Ethernet (Modbus TCP)
• Configurable alarm outputs (12 V TTL, 4–20 mA analog) for integration into facility monitoring systems (e.g., DeltaV, Siemens Desigo)
• Electronic signature capability for critical actions including method modification, calibration, and result approval

Applications

The MFT-900 serves as a core analytical platform for quality control laboratories performing routine container closure integrity verification during stability studies, batch release testing, and post-sterilization validation. It is routinely deployed for: evaluating stopper seating force effects on vial seal integrity; assessing laser-drilled micro-leakage in coated glass ampoules; validating crimping parameters for PFS assemblies; verifying hermeticity of cold-chain transport packaging; supporting comparability protocols after container component changes; and generating data for regulatory submissions (e.g., CMC sections of IND/BLA/NDA dossiers). Its non-destructive nature enables retesting of borderline samples and facilitates root cause analysis when failures occur.

FAQ

Does the MFT-900 require helium or tracer gases for operation?
No—the system operates exclusively with compressed air or nitrogen; no consumable gases are needed, reducing operational cost and safety complexity.

Can the MFT-900 be validated for use in a regulated GMP environment?
Yes—full IQ/OQ/PQ documentation packages, including protocol templates and executed reports, are provided. The system supports 21 CFR Part 11 compliance out-of-the-box with audit trail, electronic signatures, and role-based permissions.

Is custom test chamber design available for non-standard container geometries?
Yes—NeuronBC offers engineering consultation and rapid prototyping of application-specific test fixtures, including vacuum-sealed adapters for odd-shaped cartridges or nested blister packs.

What level of technical support is included post-installation?
Installation, on-site operator training, and annual preventive maintenance are standard. Remote diagnostics, 24-hour response SLA for critical issues, and loaner instrument availability during extended repairs are covered under extended service agreements.